EVO

Evotec SE ADR

1.53

Oct 30 • 3:59 PM ET -0.05 (-3.16%)

1.53

Aftermarket • 5:21 PM ET 0.00 (0.00%)

Healthcare Drug Manufacturers - Specialty & Generic Germany Small NASD

Peers: CRL RXRX SDGR ALVO ABCL DNA ABSI CERT TMO TWST

Scroll to Statements

Index	-
Market Cap	543.43M
Enterprise Value	555.18M
Income	-230.23M
Sales	836.40M
Book/sh	2.14
Cash/sh	1.50
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Jan 11, 2019
Dividend Gr. 3/5Y	- -
Payout	-
Employees	4553
IPO	Feb 05, 2004

P/E	-
Forward P/E	-
PEG	-
P/S	0.65
P/B	0.71
P/C	1.02
P/FCF	-
EV/EBITDA	-
EV/Sales	0.66
Quick Ratio	2.21
Current Ratio	2.33
Debt/Eq	0.71
LT Debt/Eq	0.62
Option/Short	No / Yes

EPS (ttm)	-0.65
EPS next Y	-0.21
EPS next Q	-0.18
EPS this Y	-131.89%
EPS next Y	72.70%
EPS next 5Y	-
EPS past 3/5Y	14.30% -
Sales past 3/5Y	4.05% 9.27%
EPS Y/Y TTM	-35.64%
Sales Y/Y TTM	-0.86%
EPS Q/Q	-10.02%
Sales Q/Q	-14.05%
Earnings	Nov 05 AMC
EPS/Sales Surpr.	-275.25% 0.91%

Insider Own	5.17%
Insider Trans	0.00%
Inst Own	0.96%
Inst Trans	-3.81%
ROA	-11.74%
ROE	-26.25%
ROIC	-18.65%
Gross Margin	10.47%
Oper. Margin	-18.62%
Profit Margin	-27.53%
SMA20	1.17%
SMA50	-7.16%
SMA200	-39.30%
Trades

Shs Outstand	355.18M
Shs Float	336.82M
Short Float	0.02%
Short Ratio	0.71
Short Interest	0.08M
52W High	4.12 -62.86%
52W Low	1.33 15.04%
Volatility	2.95% 3.63%
ATR (14)	0.06
RSI (14)	47.22
Beta	2.01
Rel Volume	0.68
Avg Volume	107.09K
Volume	73,257

Perf Week	2.00%
Perf Month	-6.99%
Perf Quarter	-21.13%
Perf Half Y	-50.49%
Perf YTD	-50.32%
Perf Year	-62.32%
Perf 3Y	-81.63%
Perf 5Y	-93.63%
Perf 10Y	-45.21%
Recom	2.33
Target Price	2.32
Prev Close	1.58
Price	1.53
Change %	-3.16%

Consensus

Buy

Avg. Price Target

$2.32

Implied Upside

+51.6%

Analysts10incl. previous ratings

Rating Distribution4 Buy · 6 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Jul 16, 2026	Downgrade	BBerenberg	Buy → Hold
Jul 15, 2026	Downgrade	TTD Cowen	Buy → Hold	$2	+30.7%
Apr 15, 2026	Resumed	HH.C. Wainwright	Buy	$7	+357.5%
Feb 03, 2026	Initiated	BBerenberg	Buy
Apr 24, 2025	Upgrade	DDeutsche Bank	Sell → Hold
Oct 07, 2024	Downgrade	JJefferies	Buy → Hold
Aug 08, 2024	Downgrade	DDeutsche Bank	Hold → Sell
Jul 29, 2024	Downgrade	MMorgan Stanley	Overweight → Equal-Weight	$15 → $6	+292.2%
Jul 11, 2024	Downgrade	DDeutsche Bank	Buy → Hold
Apr 12, 2024	Upgrade	DDeutsche Bank	Hold → Buy
Jan 18, 2024	Upgrade	RRBC Capital Mkts	Sector Perform → Outperform
Jun 23, 2023	Upgrade	MMorgan Stanley	Equal-Weight → Overweight	$12 → $16	+945.8%
Jun 16, 2023	Downgrade	BBofA Securities	Buy → Neutral	$13	+749.7%
Jun 08, 2023	Upgrade	CCitigroup	Neutral → Buy
Apr 04, 2023	Upgrade	MMorgan Stanley	Underweight → Equal-Weight	$11 → $12	+684.3%
Dec 09, 2022	Initiated	HH.C. Wainwright	Buy	$12	+684.3%
Nov 16, 2022	Downgrade	DDeutsche Bank	Buy → Hold
Aug 10, 2022	Downgrade	MMorgan Stanley	Overweight → Underweight	$23 → $16	+945.8%
Mar 02, 2022	Resumed	CCowen	Outperform
Jan 07, 2022	Resumed	CCitigroup	Neutral

Oct-29-26 03:00AM	Evotec SE to Announce Results for the First Nine Months 2026 on November 5, 2026 (PR Newswire)
Oct-15-26 02:04AM	Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board (PR Newswire)
Oct-14-26 03:47AM	Evotec shares jump after preliminary 9-month revenue, EBITDA top estimates (Investing.com) +5.95%
Sep-29-26 02:04AM	Evotec Announces Chief Scientific Officer Transition (PR Newswire)
Sep-09-26 02:00AM	Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies (PR Newswire)
02:04AM	Loading…
Sep-02-26 02:04AM	Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors (PR Newswire) +5.56%
Aug-07-26 06:10AM	Evotec and Odyssey collaborate on AI-enabled R&D (Pharmaceutical Technology)
Aug-06-26 02:16AM	Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases (PR Newswire)
Aug-03-26 08:32AM	Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168 (Business Wire)
Jul-23-26 03:00AM	Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management (Business Wire)
Jul-14-26 03:00PM	Evotec SE (EVO) Q2 2026 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... (GuruFocus.com) -11.93%
Jul-13-26 03:43PM	Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook (PR Newswire) -12.75%
Jun-30-26 02:16AM	Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics (PR Newswire)
Jun-11-26 12:02PM	Evotec Reports Results of the Annual General Meeting 2026 (PR Newswire)
Jun-02-26 01:45AM	Evotec Appoints Rui Wang as Head of Global In Silico and AI (ACCESSWIRE)
05:15PM	Loading…
May-12-26 05:15PM	Evotec SE Successfully Placed 116.1 Million Convertible Bonds (ACCESSWIRE) -9.50%
May-04-26 01:50AM	Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall (ACCESSWIRE)
Apr-30-26 03:20AM	Evotec Receives Grants to Advance Tuberculosis Treatment (ACCESSWIRE) +5.78%
Apr-29-26 04:45PM	Evotec Announces New Nomination to Board of Directors (ACCESSWIRE)
01:50AM	Evotec SE to Announce First Quarter 2026 Results on May 6, 2026 (ACCESSWIRE)
Apr-24-26 01:50AM	Evotec Announces Chief Financial Officer Transition (ACCESSWIRE)
Apr-15-26 01:50AM	Evotec Appoints Dr. Ingrid Muller as Chief Operating Officer (ACCESSWIRE)
Apr-08-26 03:00PM	Evotec SE (EVOTF) Q4 2025 Earnings Call Highlights: Strategic Gains Amid Revenue Challenges (GuruFocus.com)
05:33AM	Delta Air Lines heads earnings slate (MarketWatch)
Apr-07-26 09:16AM	What To Expect From Evotec SE (XTER:EVT) Q4 2025 Earnings (GuruFocus.com)
03:00AM	Evotec Nominates Dieter Weinand as Supervisory Board Chairman (ACCESSWIRE)
Apr-01-26 05:35AM	Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026 (ACCESSWIRE)
01:50AM	Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer (ACCESSWIRE)
Mar-23-26 03:10AM	Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses (ACCESSWIRE)
Mar-19-26 02:50AM	Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation (ACCESSWIRE)
06:17AM	Loading…
Mar-13-26 06:17AM	Evotec, Vistagen lay off staff; Immutep shares collapse on study failure (BioPharma Dive)
Mar-10-26 02:27PM	Evotec Restructuring Aims To Improve Profitability After Transition Year (Benzinga) -11.88%
07:10AM	Solvonis Therapeutics CEO on SVN-114 and PTSD market opportunity (Proactive)
Jan-18-26 12:30PM	Is Evotec SE (EVO) One of the Best Debt-Free Penny Stocks to Buy Right Now? (Insider Monkey)
Jan-08-26 01:50AM	Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access (ACCESSWIRE)
Jan-02-26 12:30AM	Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations (ACCESSWIRE)
Dec-08-25 01:20AM	Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz (ACCESSWIRE)
Dec-04-25 02:50AM	Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome (ACCESSWIRE)
Nov-12-25 02:00AM	Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership (ACCESSWIRE) +5.72%
Nov-05-25 02:00AM	Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities (ACCESSWIRE) -15.74%
Nov-04-25 04:30PM	In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties (ACCESSWIRE)
07:59AM	Earnings To Watch: Evotec SE (EVO) Reports Q3 2025 Result (GuruFocus.com)
Oct-29-25 05:10AM	Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025 (ACCESSWIRE)
Oct-27-25 02:50AM	Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb (ACCESSWIRE)
Oct-17-25 11:52AM	ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up (Zacks)
Aug-26-25 05:29PM	Analyst Report: Evotec SE (Morningstar Research)
Aug-14-25 02:41AM	Analyst Report: Evotec SE (Morningstar Research)
Aug-13-25 01:25AM	Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution (ACCESSWIRE)
Aug-12-25 09:24AM	Evotec SE (EVO) Q2 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Aug-06-25 04:15AM	Evotec SE to announce first half-year results 2025 on 13 August 2025 (ACCESSWIRE)
Aug-04-25 08:17PM	Analyst Report: Evotec SE (Morningstar Research)
Jul-30-25 01:45AM	Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site (ACCESSWIRE)
01:40AM	Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site (ACCESSWIRE)
Jul-25-25 10:57PM	Analyst Report: Evotec SE (Morningstar Research) +5.19%
Jul-22-25 08:39PM	Analyst Report: Evotec SE (Morningstar Research)
09:09AM	Morning Movers: Cleveland-Cliffs rallies after second quarter earnings release (TipRanks)
Jul-21-25 07:28PM	Analyst Report: Evotec SE (Morningstar Research) -13.38%
06:10AM	Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix (ACCESSWIRE)
05:50AM	Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance (ACCESSWIRE)
Jul-18-25 08:34PM	Analyst Report: Evotec SE (Morningstar Research)
Jul-11-25 08:14PM	Analyst Report: Evotec SE (Morningstar Research)
Jul-09-25 10:31AM	Here Is What You Need To Know Before Investing In Evotec SE (EVO) (Insider Monkey)
Jul-02-25 07:42PM	Analyst Report: Evotec SE (Morningstar Research)
Jun-25-25 01:50AM	Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury (ACCESSWIRE)
Jun-20-25 07:19PM	Analyst Report: Evotec SE (Morningstar Research) -5.29%
Jun-11-25 08:30PM	Analyst Report: Evotec SE (Morningstar Research)
Jun-03-25 05:28PM	Evotec SE: Results of the Annual General Meeting 2025 (NewMediaWire)
May-29-25 08:31PM	Analyst Report: Evotec SE (Morningstar Research) +5.03%
May-23-25 07:31PM	Analyst Report: Evotec SE (Morningstar Research) +17.37% -9.62%
May-15-25 08:26PM	Analyst Report: Evotec SE (Morningstar Research)
May-09-25 08:42PM	Analyst Report: Evotec SE (Morningstar Research) +9.97%
May-08-25 08:43PM	Analyst Report: Evotec SE (Morningstar Research) -6.24%
May-07-25 01:50AM	Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments (ACCESSWIRE)
01:43AM	Analyst Report: Evotec SE (Morningstar Research)
May-06-25 01:20AM	Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment (ACCESSWIRE)
Apr-29-25 04:30AM	Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025 (ACCESSWIRE)
Apr-28-25 07:25PM	Analyst Report: Evotec SE (Morningstar Research)
Apr-24-25 01:50AM	Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb (ACCESSWIRE)
Apr-17-25 03:58PM	Analyst Report: Evotec SE (Morningstar Research) +10.09%
02:24PM	Evotec SE (EVO) Q4 2024 Earnings Call Transcript (Seeking Alpha)
01:45AM	Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results (ACCESSWIRE)
Apr-10-25 06:00AM	Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025 (ACCESSWIRE) -5.85%
Apr-02-25 03:30PM	Is Evotec (EVO) the Best German Stock to Buy According to Hedge Funds? (Insider Monkey)
Mar-06-25 07:55PM	Analyst Report: Evotec SE (Morningstar Research) -5.66%
Mar-04-25 01:45AM	Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb (ACCESSWIRE) -6.89%
Feb-26-25 02:00AM	Evotec Announces Change in Management Board (ACCESSWIRE)
Jan-22-25 02:00AM	Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases (ACCESSWIRE)
Dec-11-24 02:00AM	Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk (ACCESSWIRE)
Nov-29-24 02:00AM	Evotec Announces Change in Management Board (ACCESSWIRE)
Nov-24-24 05:49PM	Analyst Report: Evotec SE (Morningstar Research)
Nov-22-24 11:15AM	Comment on Withdrawn Non-Binding Offer (ACCESSWIRE) -16.07%
08:35AM	Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions (PR Newswire)
Nov-20-24 12:14AM	Analyst Report: Evotec SE (Morningstar Research)
Nov-19-24 06:01PM	Is Evotec SE (EVO) the Best German Stock to Buy Now? (Insider Monkey) -7.21%
Nov-18-24 07:47PM	Analyst Report: Evotec SE (Morningstar Research)
07:00AM	Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec (PR Newswire)
Nov-15-24 10:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research) +6.67%
03:43PM	Analyst Report: Evotec SE (Morningstar Research)
Nov-14-24 05:30PM	Comment on Media Report (ACCESSWIRE) +12.09%
04:15PM	Halozyme Confirms Proposal to Combine with Evotec for 11.00 Per Share in an All-Cash Transaction (PR Newswire)

Show Previous News

Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just-Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just-Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.

CEO & Chairperson of the Management BoardDr. Christian Wojczewski Ph.D.

Chief People Officer & Member of Management BoardMs. Aurelie Dalbiez

CFO & Member of Management BoardMs. Claire Hinshelwood

COO & Member of Management BoardDr. Ingrid Mller

Executive VPDr. Sarah Fakih

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EVO

Evotec SE ADR

Upgrade your Finviz experience